Hennion & Walsh Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,762
Closed -$82.6K 843
2024
Q1
$82.6K Buy
4,762
+317
+7% +$5.63K ﹤0.01% 836
2023
Q4
$57K Sell
4,445
-2,312
-34% -$53.9K ﹤0.01% 815
2023
Q3
$250K Sell
6,757
-408
-6% -$18.2K 0.02% 695
2023
Q2
$288K Sell
7,165
-3,601
-33% -$204K 0.02% 660
2023
Q1
$781K Sell
10,766
-322
-3% -$31.2K 0.05% 409
2022
Q4
$909K Buy
11,088
+1,233
+13% +$128K 0.06% 364
2022
Q3
$931K Buy
9,855
+714
+8% +$80.2K 0.06% 341
2022
Q2
$1.78M Buy
9,141
+2,879
+46% +$470K 0.11% 217
2022
Q1
$1.45M Buy
6,262
+1,242
+25% +$395K 0.08% 270
2021
Q4
$1.98M Buy
5,020
+2,002
+66% +$843K 0.1% 236
2021
Q3
$1.35M Buy
3,018
+1,033
+52% +$370K 0.07% 295
2021
Q2
$772K Buy
1,985
+967
+95% +$345K 0.04% 419
2021
Q1
$366K Buy
+1,018
New +$450K 0.02% 553

Other funds holding ATRA